Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian H Kushner

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
Journal of Pediatric Hematology/Oncology|July 9, 2003
Curability of recurrent disseminated disease after surgery alone for local-regional neuroblastoma using intensive chemotherapy and anti-G(D2) immunotherapyBrian H Kushner, Kim Kramer, Michael P LaQuaglia, et al.
Journal of Pediatric Hematology/Oncology|January 7, 2004
Radically different treatment recommendations for newly diagnosed neuroblastoma: pitfalls in assessment of riskBrian H Kushner, Michael P LaQuaglia, Kim Kramer, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2010
High-dose cyclophosphamide-irinotecan-vincristine for primary refractory neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
International Journal of Radiation Oncology, Biology, Physics|August 17, 2002
Whole abdominopelvic radiotherapy for desmoplastic small round-cell tumorKaryn A Goodman, Suzanne L Wolden, Michael P La Quaglia, et al.
International Journal of Cancer|July 16, 2025
Rapid COJEC without myeloablative therapy for high-risk neuroblastomaBrian H Kushner, Ellen M Basu, Fiorella Iglesias Cardenas, et al.
Cancer|June 17, 2006
Ototoxicity from high-dose use of platinum compounds in patients with neuroblastomaBrian H Kushner, Amy Budnick, Kim Kramer, et al.
Journal of Pediatric Hematology/Oncology|August 18, 2017
Bevacizumab-associated Bowel Microperforation in a Patient With NeuroblastomaRachel Glincher, Anita P Price, Michael P LaQuaglia, et al.
JCO Precision Oncology|July 10, 2025
Clinical Significance of <i>TERT</i> Promoter Mutations in NeuroblastomaNatasha Persaud, Gunes Gundem, Brian H Kushner, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2008
Management and outcome of stage 3 neuroblastomaShakeel Modak, Brian H Kushner, Michael P LaQuaglia, et al.
Pediatric Blood & Cancer|January 24, 2017
Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II studyShakeel Modak, Brian H Kushner, Ellen Basu, et al.
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Journal of Pediatric Hematology/Oncology|July 9, 2003
Curability of recurrent disseminated disease after surgery alone for local-regional neuroblastoma using intensive chemotherapy and anti-G(D2) immunotherapyBrian H Kushner, Kim Kramer, Michael P LaQuaglia, et al.
Journal of Pediatric Hematology/Oncology|January 7, 2004
Radically different treatment recommendations for newly diagnosed neuroblastoma: pitfalls in assessment of riskBrian H Kushner, Michael P LaQuaglia, Kim Kramer, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2010
High-dose cyclophosphamide-irinotecan-vincristine for primary refractory neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
International Journal of Radiation Oncology, Biology, Physics|August 17, 2002
Whole abdominopelvic radiotherapy for desmoplastic small round-cell tumorKaryn A Goodman, Suzanne L Wolden, Michael P La Quaglia, et al.
International Journal of Cancer|July 16, 2025
Rapid COJEC without myeloablative therapy for high-risk neuroblastomaBrian H Kushner, Ellen M Basu, Fiorella Iglesias Cardenas, et al.
Cancer|June 17, 2006
Ototoxicity from high-dose use of platinum compounds in patients with neuroblastomaBrian H Kushner, Amy Budnick, Kim Kramer, et al.
Journal of Pediatric Hematology/Oncology|August 18, 2017
Bevacizumab-associated Bowel Microperforation in a Patient With NeuroblastomaRachel Glincher, Anita P Price, Michael P LaQuaglia, et al.
JCO Precision Oncology|July 10, 2025
Clinical Significance of <i>TERT</i> Promoter Mutations in NeuroblastomaNatasha Persaud, Gunes Gundem, Brian H Kushner, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2008
Management and outcome of stage 3 neuroblastomaShakeel Modak, Brian H Kushner, Michael P LaQuaglia, et al.
Pediatric Blood & Cancer|January 24, 2017
Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II studyShakeel Modak, Brian H Kushner, Ellen Basu, et al.
Pageof 11